News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

White Paper: Repurposing Your Lab’s Leftover COVID-19 Samples—Building New Revenue and Better Patient Outcomes through Collaboration with Life Sciences

PRESS RELEASE

FOR IMMEDIATE RELEASE

THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, TX 78669
512-264-7103 o
512-264-0969 f

Media Contact: Kristen Noonan
info@darkreport.com

AUSTIN, Texas (June 17, 2021) – DARK Daily today announced “Repurposing Your Lab’s Leftover COVID-19 Samples: Building New Revenue and Better Patient Outcomes through Collaboration with Life Sciences,” a free, 24-page white paper produced in collaboration with Ovation that explores how the rapid decline in SARS-CoV-2 testing affects molecular laboratories and the life sciences industry as a whole and offers opportunities for drug developers and labs to work together in new and beneficial ways.

When the pandemic hit in March 2020, clinical labs faced a sudden halt in routine testing, and many were able to shift quickly to COVID-19 test offerings. Fast forward one year: with the COVID-19 vaccine rollout, SARS-CoV-2 testing in clinical laboratories has rapidly declined and now labs are having to adapt again, leading forward-looking lab managers and directors to ask:

  • What will be the new balance between testing for SARS-CoV-2 and routine diagnostics?
  • Should my clinical laboratory even continue testing for coronavirus?
  • Where is the best opportunity to generate revenue now?
  • How do I transition my lab effectively—and efficiently—to best serve patients and the healthcare industry as a whole?

The new white paper, Repurposing Your Lab’s Leftover COVID-19 Samples: Building New Revenue and Better Patient Outcomes Through Collaboration with Life Science, answers these questions and more. It explores how the rapid decline in SARS-CoV-2 testing affects molecular laboratories and the life sciences industry as a whole and offers opportunities for drug developers and labs to work together in new and beneficial ways.

Click here to download or get more information on this free white paper. For additional information inquire at info@darkreport.com or call Amanda Curtis at 512-264-7103.

About DARK Daily: DARK Daily is a concise e-news/management briefing on timely topics in clinical laboratory and anatomic pathology group management. It is a solution to the dilemma facing anyone in the laboratory profession. New developments, new technology, and changing healthcare trends make it imperative to stay informed to be successful. At the same time, the Internet, cell phones, tablets, laptop computers, and wireless devices are overwhelming any one individual’s ability to absorb this crushing Tsunami of data.

-end-

;